2Galvani M, Ferrini D, Ghezzi F, et al. Cardiac markers and risk stratification: anintegrated approach[J]. Clin Chem Acta, 2001,311(1):9-17.
3Kaikita K, Ogawa H, Yasue H, et al. sol- uble P-selection is released into the coron- ary circulation after coronary spasm[J].cir- cul ation, 1995,92(7): 1726-1730.
4许丹焰 赵水平 彭卫平.冠心病患者血浆P-选择素的变化.中华心血管杂志,:439-439.
5Pearson TA, Mensah CA, Alsxander RW, et al. Markers of inflammation and cardio- vascular disease: application to clinical and public health practice: a statement for hea- lthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association [J]. Circula- tion,2003,107(3):499-511.
6Du Clos TW. Function of C-reactive pro- tein[J]. Ann Med,2000,32(4):274-278.
7Morrow DA, Antman EM, Tanaijevie M, et al. cardiac troponin I for stratification of early outcomes and the efficacy of en- oxaparin in unstable angina: a TIM1- IIB substudy[J]. Am Coil Cardiol,2000,36(6): 1812-1 817.
8Adams JE, Sicard GA, Allen BT, et al. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I[J]. N Engl J Med,1994,330(10) :670-674.
